Move from an ingredient specification to a market-specific finished-product test plan.
Educational reference—not medical advice, a supply promise or a universal manufacturing procedure.
The finished matrix changes the question
A dry extract that looks suitable on paper can behave differently in a clear beverage, gummy, capsule or emulsion. Solubility, dispersibility, taste, colour and physical stability should be evaluated in the actual matrix. A supplier assay does not replace formulation trials or finished-product safety assessment.
Define measurable acceptance criteria
Record the intended process, packaging, storage conditions and analytical method before testing. Compare colour, sediment, marker retention and sensory change over the proposed shelf-life study. Do not derive a shelf life or dosage from an encyclopedia entry. Existing solution pages are development concepts, not validated ready-to-manufacture recipes.
Choose the legal category early
Food, supplement and cosmetic uses require different reviews. A botanical’s history in one category or region does not establish permission for another preparation or use. Confirm identity, extraction method and intended conditions with a qualified regulatory specialist before finalizing labels, claims or commercial launch plans.
Confirm species, plant part and starting-material traceability
Record solvent, carrier, form and analytical method
Set acceptance criteria for the actual formulation and destination market
Make decisions using written specifications and genuine batch evidence. The checks described here are not claims of tests already performed or certificates held by ZL Botanicals; equipment and process explanations do not assert our manufacturing capabilities.
References and scope
Sources checked: . Source titles are retained as published. Status reflects this check, not a substitute for pre-market review.
US dietary supplements. Official index lists final procedural guidance (2024) separately from draft guidance (2016, 2022, 2024). Notification is not general product approval.
US food uses under specified conditions. FDA describes an August 10, 2026 proposed rule: proposal, not final rule. Recheck the docket before relying on procedural requirements.